Adverse reactions associated with henna-based cosmetic products: a twenty-two-year pharmacovigilance analysis of the FDA adverse event reporting system
Background Henna-based cosmetic products, particularly those adulterated with para-phenylenediamine (PPD), are an increasingly recognized cause of adverse skin reactions. Despite widespread consumer use, population-level pharmacovigilance data from US regulatory sources remain limited.Objective To characterize the clinical, demographic, and temporal patterns of henna-associated adverse events reported to the US Food and Drug Administration (FDA), and to identify factors associated with case seriousness.Methods Retrospective cross-sectional analysis of henna-related adverse event reports extracted from the FDA Adverse Event Reporting System Cosmetic Public Dashboard, excluding products unrelated to henna (Lawsonia inermis) such as Jagua-based formulations. Statistical analyses included chi-square, Spearman’s rank correlation, and Proportional Reporting Ratio disproportionality analysis.Results A total of 110 cases were identified (female: 65.5%; pediatric cases <18 years). Black Henna products (classified by product name) represented the largest product category (n = 47, 42.7%). The most frequently reported reactions were pruritus (39.3%), hypersensitivity (32.1%). Serious cases 50.0% of the dataset. No statistically significant association was found between gender and seriousness (χ2=0.133, p = 0.715). hypersensitivity (PRR = 1.54, 95% CI: 0.81–2.92, χ2=1.74, p = 0.187) and urticaria (PRR = 2.26, 95% CI: 0.82–6.18, χ2=2.51, p = 0.113) showed elevated PRR values; however, neither met the predefined signal threshold (PRR ≥ 2.0, χ2≥4.0, n ≥ 3), and no formal disproportionality signal was identified.Conclusions Henna-associated adverse events affect predominantly young females and pediatric patients. These findings support enhanced regulatory scrutiny under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), mandatory product labeling, and targeted consumer safety communication.
Authors
- Nagalakshmi Narasimhaswamy (ORCID: https://orcid.org/0000-0003-0495-3194)
- Shyamala Ganesan
- Basavaraj Poojar
Institutions
- Manipal University College Malaysia (MY)
- American University of Antigua (AG)
Publication Details
- Journal
- Cutaneous and Ocular Toxicology
- Published
- 2026-11-14
- DOI
- https://doi.org/10.1080/15569527.2026.2759057
- Primary Topic
- Contact Dermatitis and Allergies
- Type
- article
- Field-Weighted Citation Impact
- 0.00